Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis

被引:4
|
作者
Ginard, Daniel [1 ]
Marin-Jimenez, Ignacio [2 ]
Barreiro-de Acosta, Manuel [3 ]
Ricart, Elena [4 ,5 ]
Domenech, Eugeni [5 ,6 ]
Gisbert, Javier P. [5 ,7 ]
Esteve, Maria [5 ,8 ]
Minguez, Miguel [9 ]
机构
[1] Hosp Univ Son Espases, Serv Aparato Digest, Palma De Mallorca, Spain
[2] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Serv Med Aparato Digest, Madrid, Spain
[3] Hosp Univ Santiago de Compostela, Serv Aparato Digest, Santiago De Compostela, A Coruna, Spain
[4] Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAP, Serv Gastroenterol, Barcelona, Spain
[5] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
[6] Hosp Badalona Germans Trias & Pujol, Serv Aparato Digest, Barcelona, Spain
[7] Univ Autonoma Madrid, Hosp Univ Princesa, Inst Invest Sanitaria Hosp La Princesa IIS IP, Serv Aparato Digest, Madrid, Spain
[8] Hosp Univ Mutua Terrassa, Serv Aparato Digest, Barcelona, Spain
[9] Univ Valencia, Hosp Clin Valencia, Serv Med Digest, Valencia, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2020年 / 43卷 / 02期
关键词
Topical treatment; Ulcerative colitis; Mesalazine; Corticosteroids; 5-AMINOSALICYLIC ACID; DOUBLE-BLIND; CLINICAL-TRIAL; RECTAL MESALAMINE; MESALAZINE ENEMAS; EFFICACY; PROCTITIS; COMBINATION; FOAM; SUPPOSITORIES;
D O I
10.1016/j.gastrohep.2019.10.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although most patients with ulcerative colitis should be given topical treatment, different studies have shown that they are underused in clinical practice. The purpose of this article is to answer 10 specific questions about which drugs are available for topical use in the treatment of ulcerative colitis, and their characteristics in terms of formulation, dosage, presentation, application and proximal distribution of rectal-administered drugs. The efficacy of available topical drugs and the benefits of combining different formulations and routes of administration, and their usefulness during disease remission are evaluated. Finally, a series of recommendations addressed to patients are given on the correct application of topical treatment. (C) 2019 The Authors. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 50 条
  • [31] Positioning biologic therapy for Crohn's disease and ulcerative colitis
    Velayos F.S.
    Sandborn W.J.
    Current Gastroenterology Reports, 2007, 9 (6) : 521 - 527
  • [32] A family with collagenous colitis, ulcerative colitis, and Crohn's disease
    Chutkan, R
    Sternthal, M
    Janowitz, HD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (12): : 3640 - 3641
  • [33] Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease
    Luis Cabriada, Jose
    Vera, Isabel
    Domenech, Eugeni
    Barreiro-de Acosta, Manuel
    Esteve, Maria
    Gisbert, Javier P.
    Panes, Julia
    Gomollon, Fernando
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (03): : 127 - 146
  • [34] Chronic inflammatory intestinal diseases:Crohn's disease and ulcerative colitis.: Part 2:: Imaging of ulcerative colitis,treatment of Crohn's disease and ulcerative colitis
    Feuerbach, S
    Scholmerich, J
    RADIOLOGE, 2000, 40 (04): : 415 - 428
  • [35] Pathogenesis of Crohn's disease and ulcerative colitis
    Autschbach, F
    Otto, HF
    CHIRURGISCHE GASTROENTEROLOGIE, 1998, 14 (02): : 98 - 103
  • [36] Management of ulcerative colitis and Crohn's disease
    Baert, F
    Vermeire, S
    Noman, M
    Van Assche, G
    Haens, GD
    Rutgeerts, P
    ACTA CLINICA BELGICA, 2004, 59 (05) : 304 - 314
  • [37] Tricellulin in Crohn's disease and ulcerative colitis
    Krug, Susanne M.
    Bojarski, Christian
    Fromm, Anja
    Schulzke, Joerg Dieter
    Fromm, Michael
    FASEB JOURNAL, 2010, 24
  • [38] Managing Crohn's disease and ulcerative colitis
    Evans, S
    Ciclitira, PJ
    PRACTITIONER, 1999, 243 (1597) : 307 - +
  • [39] Autoantibodies in ulcerative colitis and Crohn's disease
    Hoier-Madsen, M.
    Vind, I.
    Locht, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : S84 - S84
  • [40] Therapies for Crohn's disease and ulcerative colitis
    Aylett, P
    IDRUGS, 2006, 9 (07) : 452 - 454